Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	76.38	-16.82	-71.20
Graham Fair Price	41.04	0.03	0.02
PEG	-77.84	-0.01	0.06
Price/Book	10.29	0.57	0.52
Price/Cash Flow	44.39	-43.54	-78.29
Prices/Earnings	44.85	-1.20	-2.17
Price/Sales	-44.85	16.99	30.80
Price/FCF	44.39	-43.54	-78.29
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-91.01	-0.04	0.43
Operating Margin	0.00	-1.47	-1.47
ROA	-100.00	-0.03	-0.01
ROE	-0.06	-0.12	-100.00
ROIC	-0.01	-0.04	-209.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.94	17.89	-94.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.47	-1.00	110.87
EPS QOQ	0.37	-0.92	148.81
FCF QOQ	0.95	-0.98	2.95
Revenue QOQ	-0.56	1.00	77.73
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14281.65	3942.20	-72.40
Days Sales Outstanding (DSO)	31.72	1501.92	4635.05
Inventory Turnover	< 0.005	0.02	262.28
Debt/Capitalization	0.57	0.07	-87.65
Quick Ratio	0.03	-0.16	511.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.02	0.02	-0.27
Cash	< 0.005	-0.02	1241.12
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	-97.79
Revenue	< 0.005	< 0.005	99.47
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.70	0.70	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-49.93	0.16	-99.68
Naive Interpretation	Member

06 - Financial Health · Bad

Rating